510(k) K230501
K230501 is an FDA 510(k) premarket notification submitted by Mir Medical International Research USA for the device "Spirobank Oxi". The FDA issued a decision of Substantially Equivalent on Dec 15, 2023. The device falls under product code BZG (Spirometer, Diagnostic), a Class II device regulated under 21 CFR 868.1840.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 15, 2023
- Date Received
- Feb 24, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Spirometer, Diagnostic
- Device Class
- Class II
- Regulation Number
- 868.1840
- Review Panel
- AN
- Submission Type
- 510(k)
Need the full FDA record for Mir Medical International Research USA? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.